Skip to main content

Fellowship

Hematology/Oncology

The Hematology/Oncology Fellowship is a three-year, ACGME-accredited program that admits four fellows per year and serves Penn State Health Milton S. Hershey Medical Center and Penn State Cancer Institute.

Explore More

The combined three-year program will prepare the trainee for obtaining board certification in both Hematology and Oncology through comprehensive and robust clinical education in hematology/oncology, regular didactic lecture series that is scheduled daily as well as tumor board and Journal Club presentations and Grand Rounds presentations to the faculty, and a curriculum that is tailored to the trainees’ professional interests, whether this focuses on an academic career in research, medical education and/or clinical care or a career focused on community hematology-oncology.

Drone view of Penn State Health Hershey, Pa. medical center in the early morning with sun shining off camera to the left.

Program Overview

To be a candidate for this ACGME-approved training position, the qualified candidate will be completing (or already has completed) a three-year ACGME-accredited internal medicine residency. It is expected that the candidate be board-eligible for internal medicine by the start of the training program.

Program Aims

The three-year combined Hematology/Oncology Fellowship aims to provide a strong foundation across the wide spectrum of hematology and oncology clinical medicine. Fellows will have an opportunity to build their skills in general hematology and oncology and work with content experts while enhancing practical and professional skills. Through outpatient clinic experiences supplemented by inpatient and consult services, fellows will be prepared for independent practice and careers with a focus of their choosing.

Diagram mapping the timeline and tracks for the  Hematology/Oncology fellowship.

Training Timeline and Tracks

The first 18 months of training are dedicated to foundations of practice through a combination of inpatient consult and outpatient clinical experiences. The second 18 months are individualized based on each fellow’s career goals with dedicated curriculum guided by four noncompetitive tracks:

  • Generalist Track: Ideal for those interested in community-based practice

  • Disease Focus Track: Ideal for those interested in academic medicine with a clinical research interest

  • Research Track/ABIM Pathway: Ideal for those interested in academic medicine with a lab or translational-based research

  • Clinician Educator Track: Ideal for those interested in academic medicine with a clinical education interest

Program Highlights

  • Varied experience

    • University academic hospital – 90 to 100% of time spent at university hospital

    • Affiliated VA hospital

    • Community-based elective at affiliated sites

  • Individualized training that is customized per fellow professional goals

  • Stem cell transplant program (allogeneic, autologous and CAR-T therapy)

  • Hemophilia and Thrombosis Center of Central Pennsylvania

  • Sickle cell clinic

  • Cancer genetics program

  • Health population sciences

  • Cooperative group affiliation

  • Opportunity to participate in basic science, laboratory research or clinical trial

  • Dedicated Cancer Institute Clinical Trials Office: Big Ten network, ACRIN, ECOG, NSABP, RTOG, pharmaceutical industry trials

  • Clinical rotations

    • Palliative care medicine

    • Pediatric hematology/oncology

    • Radiation oncology


Learn More about the Fellowship

General Application Information

The Hematology/Oncology Fellowship participates in the National Residency Matching Program (NRMP), and all applications are submitted through ERAS, the Electronic Residency Application Service.

Application Requirements: Hematology/Oncology Fellowship

  • Possess an MD or DO degree

  • Be a U.S. citizen, non-citizen national, permanent resident or holder of a J-1 training visa per institutional policies

  • Have successfully completed an ACGME-accredited internal medicine residency training program

Application Requirements: Hematology Track

  • Possess an MD or DO degree, or a doctoral degree in a related discipline

  • Be a U.S. citizen, non-citizen national, permanent resident or holder of a J-1 training visa per institutional policies

  • Have successfully completed an ACGME-accredited internal medicine residency training program

  • Have a commitment to a career focused on benign hematology, with a specific interest in hemostasis and thrombosis

What to Submit

Applicants will need to submit the following information through ERAS:

  • ERAS application

  • CV

  • Three letters of recommendation (one from the residency program director)

  • Medical school transcript

  • USMLE scores

  • Personal statement

The core faculty in the Hematology/Oncology Fellowship and the Hematology Track are full-time academic physicians committed to patient care, teaching and laboratory and clinical research.

Many allied faculty at Penn State Health Milton S. Hershey Medical Center and affiliated institutions participate in training the fellows.

Faculty research interests include endocrine oncology, transplant immunology, LGL leukemia, bleeding and clotting disorders, bone metastases, tumor biology and population science.

Contact and Leadership

Profile Photo: Myles Nickolich
Myles Nickolich, MD

Assistant Dean for Education in the Clinical Learning Environment, Penn State College of Medicine

Profile Photo: Monali Vasekar
Monali Vasekar, MD

Associate Professor, Medicine

phone icon1-717-531-6585
person iconPure
person iconFind a Doctor
Profile Photo: Beth Kohute
Beth Kohute

Program Coordinator, Endocrinology, Diabetes and Metabolism Fellowship, Hematology/Oncology Fellowship and Interventional Pulmonology Fellowship, Medicine

Mailing Address

Penn State Health Milton S. Hershey Medical Center
Division of Hematology/Oncology
500 University Dr., Mailcode CH46
Hershey, PA 17033-0850

Supporting Your Training

Curriculum Details

Sections involved in the Hematology/Oncology Fellowship include:

  • Continuity clinic with individualized cohort of patients for different disease types

  • Outpatient clinic rotations

  • Hematology consultation service

  • Oncology consultation service

  • Inpatient hematology/oncology team

  • Hematology lab/blood bank

  • Gynecologic oncology and genetics

  • Lebanon VA Hospital

  • Community practice elective at affiliated sites

  • Palliative care

  • Radiation oncology therapy

  • Stem cell transplant

  • Research

The Quality Oncology Practice Initiative (QOPI) is a twice-a-year chart review that serves as the ACGME-required Practice-Based Learning improvement project. Learn more about QOPI here.

Didactic learning includes the following:

  • ACGME Core Competency Lecture Series

  • Cancer Institute Interdisciplinary Conference

  • Hematology/Oncology Grand Rounds

  • Medicine Grand Rounds

  • Fellows’ noon conferences are held Monday-Friday on the following topics:

    • High-yield disease based management topics by Heme/Onc Faculty

    • Biostatistics

    • Fellow Journal Club

    • Ethics and communications

    • Genetics

    • Pharmacology

    • Board reviews

    • Peripheral slide series

    • Fellow Tumor Board

    • Hematology Case Conference

    • Benign Hematology Conference series

    • Fellow feedback sessions

  • Tumor-specific conferences

    • Brain tumor

    • Breast

    • Gastrointestinal foregut tumor conference

    • Gastrointestinal conference

    • Genitourinary

    • Head and neck

    • Melanoma and cutaneous malignancies

    • Sarcoma

    • Thoracic

    • Malignant hematology

    • Benign hematology

    • Gynecologic

Evaluations of the fellows will be completed using the following methods:

  • Monthly rotational evaluations

  • Individual semi-annual reviews

  • Multisource (360-degree) evaluations

  • Self-assessments

  • Systematic annual program review

  • Each fellow must attend a conference for bone marrow biopsy training.

  • Each fellow must complete five supervised marrows with either an experienced APP or senior fellow with satisfactory sampling. Each fellow will be assigned to an experienced APP team or senior fellow to complete five supervised marrows in their first month of fellowship

  • After completion of five supervised marrows, each fellow must arrange to have one witnessed bone marrow biopsy by the program director or associate program director or other approved hematology attending with satisfactory sampling. Attending will “sign off” on fellow’s ability to perform marrows on their own.

Fellow Honors and Recognitions

Penn State College of Medicine and Penn State Health Milton S. Hershey Medical Center accept ongoing nominations for the Exceptional Moments in Teaching award.

The award, given monthly by the Office for a Respectful Learning Environment, accepts nominations from College of Medicine students who are invited to submit narratives about faculty members, residents, fellows, nurses or any other educators who challenge them and provide an exceptional learning experience. See more about the award here.

Previous nominees from the Hematology/Oncology Fellowship are listed here. Click the + next to a nominee name to read their nominator’s comments.

News from Hematology/Oncology

News from Penn State Cancer Institute